<HashMap><database>ENA</database><scores/><additional><omics_type>Genomics</omics_type><center_name>Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine</center_name><full_dataset_link>https://www.ebi.ac.uk/ena/browser/view/PRJEB55091</full_dataset_link><long_description>Oxidative stress and cell apoptosis play pivotal roles in the pathogenesis of doxorubicin (DOX)-induced myocardial injury. HSP-17 is a peptide that is lowly expressed in heart tissue from DOX-treated mice. It has a high bioactivity and interspecies sequence consistency, and is predicted to have myocardial protective effects. We have proved that HSP-17 peptide can increase cell viability, protect mitochondrial potential, reduce LDH levels, and reduce ROS and cardiomyocyte apoptosis. To investigate the mechanism underlying cardioprotective role of HSP-17, H9c2 cells were pretreated with 10 μM HSP-17 or scramble peptide for 2 hrs and then insuled by 1 μM DOX for 24 hrs.Total RNA was harvested, and then subjected to quality control and purification. cDNA libraries were created and sequenced on an Illumina HiSeq System.</long_description><repository>ENA</repository></additional><is_claimable>false</is_claimable><name>undefined</name><description>Effect of HSP-17 peptide on gene expression of doxorubicin-treated H9c2 cells.</description><dates><last_updated>2022-07-30</last_updated><first_public>2022-07-30</first_public></dates><accession>PRJEB55091</accession><cross_references/></HashMap>